Zimmer Biomet Holdings, Inc. (ZBH)
Company Info
Highlights
$20.25B
$4.43
23.11
1.27
$7.70B
$5.11B
$1.79B
$89.92 - $121.18
$122.35
3.64%
2.96
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Zimmer Biomet Holdings, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Zimmer Biomet Holdings, Inc. (ZBH) returned -9.77% year-to-date (YTD) and -20.60% over the past 12 months. Over the past 10 years, ZBH returned -0.63% annually, underperforming the S&P 500 benchmark at 10.43%.
ZBH
-9.77%
-7.47%
-12.11%
-20.60%
-3.52%
-0.63%
^GSPC (Benchmark)
-3.70%
13.67%
-5.18%
9.18%
14.14%
10.43%
Monthly Returns
The table below presents the monthly returns of ZBH, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 3.64% | -4.71% | 8.73% | -8.95% | -7.70% | -9.77% | |||||||
| 2024 | 3.20% | -0.99% | 6.33% | -8.86% | -4.27% | -5.54% | 2.60% | 3.69% | -6.30% | -0.95% | 4.84% | -5.56% | -12.46% |
| 2023 | -0.13% | -2.72% | 4.50% | 7.15% | -8.02% | 14.53% | -5.12% | -13.77% | -5.59% | -6.96% | 11.40% | 4.84% | -3.81% |
| 2022 | -3.16% | 3.39% | 3.85% | -5.59% | -0.45% | -12.41% | 5.07% | -3.69% | -1.44% | 8.42% | 5.96% | 6.36% | 4.32% |
| 2021 | -0.27% | 6.11% | -1.68% | 10.67% | -4.98% | -4.32% | 1.62% | -7.94% | -2.56% | -2.21% | -16.43% | 6.42% | -17.02% |
| 2020 | -1.19% | -7.94% | -25.57% | 18.42% | 5.55% | -5.33% | 12.99% | 4.46% | -3.19% | -2.97% | 12.88% | 3.50% | 3.77% |
| 2019 | 5.63% | 13.29% | 3.08% | -3.56% | -7.49% | 3.56% | 14.77% | 3.01% | -1.21% | 0.70% | 5.10% | 3.19% | 45.38% |
| 2018 | 5.35% | -8.55% | -5.99% | 5.62% | -3.18% | 0.16% | 12.63% | -1.51% | 6.54% | -13.60% | 3.02% | -11.16% | -13.30% |
| 2017 | 14.66% | -1.06% | 4.50% | -2.01% | -0.37% | 7.91% | -5.51% | -5.81% | 2.68% | 3.87% | -3.72% | 3.26% | 17.86% |
| 2016 | -3.25% | -2.47% | 10.40% | 8.57% | 5.48% | -1.22% | 8.94% | -1.17% | 0.51% | -18.94% | -3.36% | 1.55% | 1.46% |
| 2015 | -1.16% | 7.40% | -2.20% | -6.54% | 4.07% | -4.26% | -4.72% | -0.49% | -9.09% | 11.33% | -3.40% | 1.78% | -8.79% |
| 2014 | 0.84% | -0.14% | 1.03% | 2.35% | 7.80% | -0.26% | -3.65% | -0.76% | 1.47% | 10.63% | 0.94% | 1.20% | 22.76% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of ZBH is 13, meaning it’s performing worse than 87% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Zimmer Biomet Holdings, Inc. (ZBH) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Zimmer Biomet Holdings, Inc. provided a 1.01% dividend yield over the last twelve months, with an annual payout of $0.96 per share. The company has been increasing its dividends for 12 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.96 | $0.96 | $0.96 | $0.96 | $0.93 | $0.93 | $0.93 | $0.93 | $0.93 | $0.93 | $0.85 | $0.85 |
Dividend yield | 1.01% | 0.91% | 0.79% | 0.75% | 0.76% | 0.62% | 0.64% | 0.93% | 0.80% | 0.93% | 0.86% | 0.78% |
Monthly Dividends
The table displays the monthly dividend distributions for Zimmer Biomet Holdings, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.24 | |||||||
| 2024 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.24 | $0.96 |
| 2023 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.24 | $0.96 |
| 2022 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.24 | $0.96 |
| 2021 | $0.00 | $0.00 | $0.23 | $0.00 | $0.00 | $0.23 | $0.00 | $0.00 | $0.23 | $0.00 | $0.00 | $0.23 | $0.93 |
| 2020 | $0.00 | $0.00 | $0.23 | $0.00 | $0.00 | $0.23 | $0.00 | $0.00 | $0.23 | $0.00 | $0.00 | $0.23 | $0.93 |
| 2019 | $0.00 | $0.00 | $0.23 | $0.00 | $0.00 | $0.23 | $0.00 | $0.00 | $0.23 | $0.00 | $0.00 | $0.23 | $0.93 |
| 2018 | $0.00 | $0.00 | $0.23 | $0.00 | $0.00 | $0.23 | $0.00 | $0.00 | $0.23 | $0.00 | $0.00 | $0.23 | $0.93 |
| 2017 | $0.00 | $0.00 | $0.23 | $0.00 | $0.00 | $0.23 | $0.00 | $0.00 | $0.23 | $0.00 | $0.00 | $0.23 | $0.93 |
| 2016 | $0.00 | $0.00 | $0.23 | $0.00 | $0.00 | $0.23 | $0.00 | $0.00 | $0.23 | $0.00 | $0.00 | $0.23 | $0.93 |
| 2015 | $0.00 | $0.00 | $0.21 | $0.00 | $0.21 | $0.00 | $0.00 | $0.00 | $0.21 | $0.00 | $0.00 | $0.21 | $0.85 |
| 2014 | $0.21 | $0.00 | $0.00 | $0.21 | $0.00 | $0.00 | $0.21 | $0.00 | $0.00 | $0.21 | $0.85 |
Dividend Yield & Payout
Dividend Yield
Zimmer Biomet Holdings, Inc. has a dividend yield of 1.01%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
Zimmer Biomet Holdings, Inc. has a payout ratio of 15.84%, which is below the market average. This means Zimmer Biomet Holdings, Inc. returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Zimmer Biomet Holdings, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Zimmer Biomet Holdings, Inc. was 65.03%, occurring on Mar 9, 2009. Recovery took 1182 trading sessions.
The current Zimmer Biomet Holdings, Inc. drawdown is 43.34%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -65.03% | Apr 27, 2007 | 470 | Mar 9, 2009 | 1182 | Nov 14, 2013 | 1652 |
| -49.73% | Feb 18, 2020 | 22 | Mar 18, 2020 | 203 | Jan 6, 2021 | 225 |
| -46.1% | Apr 30, 2021 | 1008 | May 5, 2025 | — | — | — |
| -40.49% | Jul 8, 2004 | 514 | Jul 20, 2006 | 185 | Apr 17, 2007 | 699 |
| -26.23% | Aug 10, 2016 | 68 | Nov 14, 2016 | 166 | Jul 14, 2017 | 234 |
Volatility
Volatility Chart
The current Zimmer Biomet Holdings, Inc. volatility is 14.50%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Zimmer Biomet Holdings, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Zimmer Biomet Holdings, Inc., comparing actual results with analytics estimates. The company met analyst expectations for EPS in the past quarter.
Valuation
The Valuation section provides an overview of how Zimmer Biomet Holdings, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for ZBH, comparing it with other companies in the Medical Devices industry. Currently, ZBH has a P/E ratio of 23.1. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for ZBH compared to other companies in the Medical Devices industry. ZBH currently has a PEG ratio of 1.3. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ZBH relative to other companies in the Medical Devices industry. Currently, ZBH has a P/S ratio of 2.7. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ZBH in comparison with other companies in the Medical Devices industry. Currently, ZBH has a P/B value of 1.6. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |